Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (364)

Clear all filters
Clear all filters

Glofitamab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager

Ibritumomab Tiuxetan (Y-90)

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Idasanutlin

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

MDM2 Inhibitor

Idelalisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Inavolisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Interferon Alfa-2a

Immunotherapy (Cytokine)

Therapeutic Category

Immunotherapy (Cytokine)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Interferon / Interleukin

Interferon Alfa-2b

Immunotherapy (Cytokine)

Therapeutic Category

Immunotherapy (Cytokine)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Interferon / Interleukin

Iobenguane I-131

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Iodine-131 Tositumomab

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Linperlisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Linvoseltamab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager

Milademetan

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

MDM2 Inhibitor